Genital human papillomavirus infections

Current Opinion in Urology

Volumn 12, Issue 1, 2002, Pages 57-61

  Schneede, P ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; IMMUNOMODULATING AGENT; INTERFERON; PODOPHYLLOTOXIN;

DRUG INDUCED DISEASE; FEMALE; GENITAL TRACT INFECTION; HIGH RISK POPULATION; HUMAN; LASER SURGERY; MALE; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SQUAMOUS CELL CARCINOMA; VIRUS INFECTION; VIRUS PATHOGENESIS; WART VIRUS;

FEMALE; HUMANS; IMMUNOTHERAPY; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS;

EID: 0036140234     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200201000-00011     Document Type: Review

References (46)

1. Asymptomatic penile HPV infection: A prospective study
2. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day
3. Analysis of genomic sequences of 95 papillomavirus types: Uniting typing, phylogeny, and taxonomy
4. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis
5. Human papilloma virus status and chromosomal imbalances in primary cervical carcinomas and tumour cell lines
6. Deletion of the FHIT gene in neoplastic and invasive cervical lesions is related to high-risk HPV infection but is independent of histopathological features
7. Human papilloma virus in melanoma biopsy specimens and its relation to melanoma progression
8. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: An alternative mechanism for tumor development
9. Evaluation of the possible protective role of adeno-associated virus type 2 infection in HPV-associated premalignant disease of the cervix
10. The importance of psychosocial factors in the prevention of HPV infection and cervical cancer
11. Self-disclosure of HPV infection to sexual partners
12. Identification of multiple genital HPV types and sequence variants by consensus and nested type-specific PCR coupled with cycle sequencing
13. Distribution of HPV 53, HPV 73 and CP8304 in genital epithelial lesions with different grades of dysplasia
14. Evaluation of HPV testing by hybrid capture II for routine gynecologic screening
15. HPV and cervical cancer: Epidemiology, detection and immunological aspects
16. Epidemiologic and mucosal immunologic aspects of HPV infection and HPV-related cervical neoplasia in the lower female genital tract: A review
17. Screening for cervical cancer: Should we test for infection with high-risk HPV?
18. A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: Summary and conclusions
19. Usefulness of human papilloma virus testing in the screening of cervical cancer precursor lesions: A retrospective study in 314 cases
20. Human papillomavirus and p53 protein immunoreactivity in condylomata acuminatum and squamous cell carcinoma of penis
21. Squamous papilloma of the urinary tract is unrelated to condyloma acuminata
22. Human papillomavirus (HPV) DNA in penile carcinomas in Argentina: Analysis of primary tumors and lymph nodes
23. Human papillomavirus as a prognostic factor in carcinoma of the penis
24. Evaluation of partners of women with HPV infection
25. Human papillomaviruses (HPV) in urology. Part I: 10-years results of interdisciplinary HPV diagnostics
26. Fluorescence urethroscopy following instillation of 5-aminolevulinic acid: A new procedure for detecting clinical and subclinical HPV lesions of the urethra
27. Photodynamic investigation of mucosa-associated human papillomavirus efflorescences
28. HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients
29. Skin diseases following organ transplantation: Risk factors and new therapeutic approaches
30. Penile cancer and human papilloma virus (HPV) in a human immunodeficiency virus (HIV)-infected patient
31. The Uganda study on HPV variants and genital cancers
32. Genital human papillomavirus infection and associated penile intraepithelial neoplasia in males infected with the human immunodeficiency virus
33. Human papillomaviruses (HPV) in urology. Part II: 10-year evaluation of differential HPV therapy
34. Efficacy in treatment of subclinical cervical HPV infection without intraepithelial neoplasia: Systemic review
35. Clinical and viral clearance of human papillomavirus (HPV)-associated genital lesions by Nd:YAG-laser treatment
36. Margin clearance and HPV infection do not influence the cure rates of early neoplasia of the uterine cervix by laser conization
37. Urethral condylomata. A therapeutic challenge
38. Immunotherapy of gynaecological high-risk human papilloma virus infection with human leukocyte ultrafiltrate
39. Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day
40. Successful treatment of actinic keratosis with imiquimod cream 5%: A report of six cases
41. Imiquimod: A new therapy for bowenoid papulosis?
42. European course on HPV associated pathology: Guidelines for primary care physicians for the diagnosis and management of anogenital warts
43. Condylomata acuminata and other HPV-associated manifestations of the genitals and urethra. Guidelines of the German STD Society (DSTDG)
44. Diagnosis and therapy of human papillomavirus-associated genital lesions. Guideline of the German Urology Society (DGU)
45. Recommendations for the diagnosis and treatment of HPV infections of the female tract
46. Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer